Hepatocellular carcinoma is one of the top ten causes of cancer death in the United States, as well as the most rapidly increasing cause of cancer death in men. Understanding the nuances of early liver cancer detection, and treating underlying liver diseases prior to cancer development, have been more urgently needed.
Dr. Maarouf Hoteit, Assistant Professor of Clinical Medicine, Director of the Multidisciplinary Liver Tumor Clinic, and Program Director of the Transplant Hepatology Fellowship at the University of Pennsylvania Perelman School of Medicine joins Dr. Barry Mennen to discuss diagnostic, medical and surgical priorities for managing hepatocellular carcinoma.